🎯 check AZD5363 (Capivasertib) product page
AZD5363 (Capivasertib) is a potent, ATP-competitive pan-AKT inhibitor. It affects PI3K/AKT/mTOR signaling by binding to the AKT kinase domain and suppressing downstream effectors, effectively inhibiting tumor cell proliferation and promoting apoptosis.